Abstract
The aim of this study was to derive a new plan-scoring index using normal tissue complication probabilities to verify different plans in the selection of personalized treatment. Plans for 12 patients treated with tomotherapy were used to compare scoring for ranking. Dosimetric and biological indexes were analyzed for the plans for a clearly distinguishable group (n = 7) and a similar group (n = 12), using treatment plan verification software that we developed. The quality factor (QF) of our support software for treatment decisions was consistent with the final treatment plan for the clearly distinguishable group (average QF = 1.202, 100% match rate, n = 7) and the similar group (average QF = 1.058, 33% match rate, n = 12). Therefore, we propose a normal tissue complication probability (NTCP) based on the plan scoring index for verification of different plans for personalized treatment-plan selection. Scoring using the new QF showed a 100% match rate (average NTCP QF = 1.0420). The NTCP-based new QF scoring method was adequate for obtaining biological verification quality and organ risk saving using the treatment-planning decision-support software we developed for prostate cancer.
Original language | English |
---|---|
Pages (from-to) | 306-311 |
Number of pages | 6 |
Journal | Journal of the Korean Physical Society |
Volume | 72 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2018 Jan 1 |
Bibliographical note
Publisher Copyright:© 2018, The Korean Physical Society.
Keywords
- Biological index
- Dosimetric index
- Normal tissue complication probability
- Quality factor
- Treatment planning decision support system
ASJC Scopus subject areas
- General Physics and Astronomy